Last 12 months
Inside the activity.
1 purchase rows · 65 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 23 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2025 Filed Dec 2, 2025 23:34 UTC |
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
|
GrantCommon Stock | 250 | $74.72 | $18,678.75 |
DisclosureSEC source: 0001932682-25-000005 · wk-form4_1764718472.xml · nonDerivative · entry 1 Turakhia Minang · CIK 0001932682 · CHIEF MED/SCI OFCR EVP ADVTECH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,643 F1 · shares: Mr. Turakhia is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period June 1, 2025 through November 30, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 23:22 UTC |
Rosenbaum Marc WadeChief Accounting Officer
|
GrantCommon Stock | 2 | $119.55 | $239.11 |
DisclosureSEC source: 0001929535-25-000008 · wk-form4_1764717763.xml · nonDerivative · entry 1 Rosenbaum Marc Wade · CIK 0001929535 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,881 F1 · shares: Mr. Rosenbaum is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period June 1, 2025 through November 30, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:33 UTC |
TALWALKAR ABHIJIT YDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,312 | $10.71 Strike: $10.71 | $56,891.52 |
DisclosureSEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · derivative · entry 8 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,624 Underlying: Common Stock · 5,312 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.expiration_date: The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:33 UTC |
TALWALKAR ABHIJIT YDirector
|
SaleCommon Stock | 89 | $177.85 | $15,828.65 |
DisclosureSEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 7 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,299 F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:33 UTC |
TALWALKAR ABHIJIT YDirector
|
SaleCommon Stock | 637 | $175.96 | $112,084.16 |
DisclosureSEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 6 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,388 F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. F6 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $175.7650 to a high of $176.1150, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:33 UTC |
TALWALKAR ABHIJIT YDirector
|
SaleCommon Stock | 1,300 | $174.94 | $227,427.46 |
DisclosureSEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 5 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,025 F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. F5 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $174.7500 to a high of $175.2800, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:33 UTC |
TALWALKAR ABHIJIT YDirector
|
SaleCommon Stock | 1,585 | $174.38 | $276,395.31 |
DisclosureSEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 4 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,325 F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. F4 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $173.8700 to a high of $174.7000 inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:33 UTC |
TALWALKAR ABHIJIT YDirector
|
SaleCommon Stock | 222 | $172.83 | $38,367.15 |
DisclosureSEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 3 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,910 F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $172.7450 to a high of $172.9600, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:33 UTC |
TALWALKAR ABHIJIT YDirector
|
SaleCommon Stock | 1,479 | $172.32 | $254,858.91 |
DisclosureSEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 2 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,132 F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. F2 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $171.7350 to a high of $172.7000, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:33 UTC |
TALWALKAR ABHIJIT YDirector
|
Exercise / conversionCommon Stock | 5,312 | $10.71 | $56,891.52 |
DisclosureSEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 1 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 22:04 UTC |
Blackford Quentin S.Director · President and CEO
|
SaleCommon Stock | 14,059 | $182.94 | $2,571,907.07 |
DisclosureSEC source: 0001612451-25-000005 · wk-form4_1762293847.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,979 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 16:30 UTC |
Wilson Daniel G.Chief Financial Officer
|
SaleCommon Stock | 8,000 | $207.44 | $1,659,520.00 |
DisclosureSEC source: 0001860745-25-000009 · wk-form4_1762205433.xml · nonDerivative · entry 1 Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,470 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 14, 2024. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 17:14 UTC |
Wilson Daniel G.Chief Financial Officer
|
SaleCommon Stock | 5,000 | $175.00 | $875,000.00 |
DisclosureSEC source: 0001860745-25-000007 · wk-form4_1757020478.xml · nonDerivative · entry 1 Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,470 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by Mr. Wilson on November 14, 2024. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 16:30 UTC |
Wilson Daniel G.Chief Financial Officer
|
SaleCommon Stock | 737 | $167.28 | $123,285.36 |
DisclosureSEC source: 0001860745-25-000005 · wk-form4_1756931413.xml · nonDerivative · entry 1 Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,470 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs. Read SEC document |
| August 22, 2025 Filed Aug 22, 2025 22:27 UTC |
Shrishrimal SumiEVP, Chief Risk Officer
|
SaleCommon Stock | 653 | $167.12 | $109,129.36 |
DisclosureSEC source: 0001850687-25-000006 · wk-form4_1755901669.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,032 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 23, 2025. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:38 UTC |
TALWALKAR ABHIJIT YDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,312 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001316065-25-000005 · wk-form4_1755031077.xml · derivative · entry 4 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,936 Underlying: Common Stock · 5,312 shares Expires 2026-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.expiration_date: The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:38 UTC |
TALWALKAR ABHIJIT YDirector
|
SaleCommon Stock | 2,129 | $158.68 | $337,828.02 |
DisclosureSEC source: 0001316065-25-000005 · wk-form4_1755031077.xml · nonDerivative · entry 3 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,299 F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 11, 2025. The actual sale prices ranged from a low of $158.3100 to a high of $159.0000, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:38 UTC |
TALWALKAR ABHIJIT YDirector
|
SaleCommon Stock | 3,183 | $157.57 | $501,552.63 |
DisclosureSEC source: 0001316065-25-000005 · wk-form4_1755031077.xml · nonDerivative · entry 2 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,428 F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. F2 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 11, 2025. The actual sale prices ranged from a low of $157.2350 to a high of $158.1800, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:38 UTC |
TALWALKAR ABHIJIT YDirector
|
Exercise / conversionCommon Stock | 5,312 | $10.71 | $56,891.52 |
DisclosureSEC source: 0001316065-25-000005 · wk-form4_1755031077.xml · nonDerivative · entry 1 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:39 UTC |
Rosenbaum Marc WadeChief Accounting Officer
|
SaleCommon Stock | 226 | $158.93 | $35,918.18 |
DisclosureSEC source: 0001929535-25-000006 · wk-form4_1755031145.xml · nonDerivative · entry 1 Rosenbaum Marc Wade · CIK 0001929535 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,879 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2025. Read SEC document |
| August 06, 2025 Filed Aug 7, 2025 20:57 UTC |
Patterson ChadChief Commercial Officer
|
SaleCommon Stock | 2,555 | $158.97 | $406,168.35 |
DisclosureSEC source: 0001850152-25-000005 · wk-form4_1754600252.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,667 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024. Read SEC document |
| August 05, 2025 Filed Aug 6, 2025 21:10 UTC |
Blackford Quentin S.Director · President and CEO
|
SaleCommon Stock | 306 | $165.00 | $50,490.00 |
DisclosureSEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 7 Blackford Quentin S. · CIK 0001612451 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 179,038 F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025. Read SEC document |
| August 05, 2025 Filed Aug 6, 2025 21:10 UTC |
Blackford Quentin S.Director · President and CEO
|
SaleCommon Stock | 3,174 | $163.93 | $520,300.81 |
DisclosureSEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 6 Blackford Quentin S. · CIK 0001612451 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 179,344 F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025. F7 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $163.50 to a high of $164.23, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. Read SEC document |
| August 05, 2025 Filed Aug 6, 2025 21:10 UTC |
Blackford Quentin S.Director · President and CEO
|
SaleCommon Stock | 1,514 | $163.30 | $247,229.99 |
DisclosureSEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 5 Blackford Quentin S. · CIK 0001612451 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,518 F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025. F6 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $162.71 to a high of $163.44, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. Read SEC document |
| August 05, 2025 Filed Aug 6, 2025 21:10 UTC |
Blackford Quentin S.Director · President and CEO
|
SaleCommon Stock | 1,600 | $161.92 | $259,076.00 |
DisclosureSEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 4 Blackford Quentin S. · CIK 0001612451 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 184,032 F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025. F5 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $161.63 to a high of $162.41, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. Read SEC document |
| August 05, 2025 Filed Aug 6, 2025 21:10 UTC |
Blackford Quentin S.Director · President and CEO
|
SaleCommon Stock | 4,905 | $160.73 | $788,360.54 |
DisclosureSEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 3 Blackford Quentin S. · CIK 0001612451 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,632 F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025. F4 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $160.49 to a high of $161.45, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. Read SEC document |
| August 05, 2025 Filed Aug 6, 2025 21:10 UTC |
Blackford Quentin S.Director · President and CEO
|
SaleCommon Stock | 9,775 | $160.06 | $1,564,576.73 |
DisclosureSEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 2 Blackford Quentin S. · CIK 0001612451 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,537 F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025. F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $159.53 to a high of $160.44, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. Read SEC document |
| August 05, 2025 Filed Aug 6, 2025 21:10 UTC |
Blackford Quentin S.Director · President and CEO
|
SaleCommon Stock | 8,726 | $158.85 | $1,386,157.39 |
DisclosureSEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,312 F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025. F2 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $158.47 to a high of $159.42, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 21:02 UTC |
Patterson ChadChief Commercial Officer
|
SaleCommon Stock | 2,707 | $164.36 | $444,921.71 |
DisclosureSEC source: 0001388658-25-000199 · wk-form4_1754427734.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,222 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 21:03 UTC |
Smith MervinEVP Strategic Business Ops
|
SaleCommon Stock | 616 | $164.36 | $101,245.58 |
DisclosureSEC source: 0001388658-25-000200 · wk-form4_1754427800.xml · nonDerivative · entry 1 Smith Mervin · CIK 0001985217 · EVP Strategic Business Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,838 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs. Read SEC document |
| July 07, 2025 Filed Jul 8, 2025 20:22 UTC |
OBOYLE KEVIN CDirector
|
GrantCommon Stock | 2,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000184 · wk-form4_1752006159.xml · nonDerivative · entry 1 OBOYLE KEVIN C · CIK 0001203567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,035 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 33.33% of the RSUs vest on July 7, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| July 07, 2025 Filed Jul 8, 2025 16:23 UTC |
MCGINNIS KAREN KDirector
|
GrantCommon Stock | 2,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000185 · wk-form4_1752006189.xml · nonDerivative · entry 1 MCGINNIS KAREN K · CIK 0001188264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,035 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 33.33% of the RSUs vest on July 7, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| July 02, 2025 Filed Jul 2, 2025 21:51 UTC |
Turakhia MinangEVP, CMO & CSO
|
SaleCommon Stock | 1,420 | $145.41 | $206,482.20 |
DisclosureSEC source: 0001388658-25-000173 · wk-form4_1751493074.xml · nonDerivative · entry 1 Turakhia Minang · CIK 0001932682 · EVP, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,393 F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 21:51 UTC |
Freeman Sean ClintonEVP, Strategy & Corp Devt
|
GrantCommon Stock | 6,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000174 · wk-form4_1751493097.xml · nonDerivative · entry 1 Freeman Sean Clinton · CIK 0002074661 · EVP, Strategy & Corp Devt 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,761 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on July 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| June 23, 2025 Filed Jun 24, 2025 16:16 UTC |
Wilson Daniel G.Chief Financial Officer
|
SaleCommon Stock | 3,000 | $150.00 | $450,000.00 |
DisclosureSEC source: 0001388658-25-000164 · wk-form4_1750796192.xml · nonDerivative · entry 1 Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,307 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 14, 2024. Read SEC document |
| June 23, 2025 Filed Jun 24, 2025 20:15 UTC |
Patterson ChadChief Commercial Officer
|
SaleCommon Stock | 936 | $150.00 | $140,400.00 |
DisclosureSEC source: 0001388658-25-000162 · wk-form4_1750796127.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,929 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:21 UTC |
Patterson ChadChief Commercial Officer
|
SaleCommon Stock | 363 | $150.00 | $54,450.00 |
DisclosureSEC source: 0001388658-25-000158 · wk-form4_1749673286.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,865 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:18 UTC |
Shrishrimal SumiEVP, Chief Risk Officer
|
SaleCommon Stock | 1,608 | $140.21 | $225,457.68 |
DisclosureSEC source: 0001388658-25-000156 · wk-form4_1748981875.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,685 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:17 UTC |
Rosenbaum Marc WadeChief Accounting Officer
|
SaleCommon Stock | 696 | $140.21 | $97,586.16 |
DisclosureSEC source: 0001388658-25-000155 · wk-form4_1748981843.xml · nonDerivative · entry 2 Rosenbaum Marc W. · CIK 0001929535 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,105 F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:18 UTC |
Shrishrimal SumiEVP, Chief Risk Officer
|
GrantCommon Stock | 176 | $71.46 | $12,576.96 |
DisclosureSEC source: 0001388658-25-000156 · wk-form4_1748981875.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,293 F1 · shares: Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:16 UTC |
Patterson ChadChief Commercial Officer
|
GrantCommon Stock | 298 | $71.46 | $21,295.08 |
DisclosureSEC source: 0001388658-25-000154 · wk-form4_1748981789.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,228 F1 · shares: Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:16 UTC |
Blackford Quentin S.Director · President and CEO
|
GrantCommon Stock | 297 | $71.46 | $21,223.62 |
DisclosureSEC source: 0001388658-25-000153 · wk-form4_1748981758.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,038 F1 · shares: Mr. Blackford is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:17 UTC |
Rosenbaum Marc WadeChief Accounting Officer
|
GrantCommon Stock | 294 | $71.46 | $21,009.24 |
DisclosureSEC source: 0001388658-25-000155 · wk-form4_1748981843.xml · nonDerivative · entry 1 Rosenbaum Marc W. · CIK 0001929535 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,801 F1 · shares: Mr. Rosenbaum is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:15 UTC |
Turakhia MinangEVP, CMO & CSO
|
GrantCommon Stock | 318 | $74.72 | $23,760.96 |
DisclosureSEC source: 0001388658-25-000152 · wk-form4_1748981735.xml · nonDerivative · entry 1 Turakhia Minang · CIK 0001932682 · EVP, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,813 F1 · shares: Mr. Turakhia is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| May 28, 2025 Filed May 29, 2025 16:04 UTC |
SNYDERMAN RALPHDirector
|
GrantCommon Stock | 1,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000134 · wk-form4_1748549087.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,288 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. Read SEC document |
| May 28, 2025 Filed May 29, 2025 16:01 UTC |
RUBASH MARK JDirector
|
GrantCommon Stock | 1,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000127 · wk-form4_1748548910.xml · nonDerivative · entry 1 RUBASH MARK J · CIK 0001209186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,788 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. Read SEC document |
| May 28, 2025 Filed May 29, 2025 20:03 UTC |
TALWALKAR ABHIJIT YDirector
|
GrantCommon Stock | 1,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000131 · wk-form4_1748549004.xml · nonDerivative · entry 1 TALWALKAR ABHIJIT Y · CIK 0001316065 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,299 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. Read SEC document |
| May 28, 2025 Filed May 29, 2025 20:06 UTC |
YOOR BRIAN BDirector
|
GrantCommon Stock | 1,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000138 · wk-form4_1748549182.xml · nonDerivative · entry 1 YOOR BRIAN B · CIK 0001643528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,598 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. Read SEC document |
| May 28, 2025 Filed May 29, 2025 20:05 UTC |
Bodaken Bruce G.Director
|
GrantCommon Stock | 1,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000136 · wk-form4_1748549132.xml · nonDerivative · entry 1 Bodaken Bruce G. · CIK 0001527009 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,638 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. Read SEC document |
| May 28, 2025 Filed May 29, 2025 20:04 UTC |
Bairey Merz Cathleen NoelDirector
|
GrantCommon Stock | 1,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000132 · wk-form4_1748549040.xml · nonDerivative · entry 1 Bairey Merz Cathleen Noel · CIK 0001738783 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,973 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.